The AtaCor EV Temporary Pacing System is designed to enable reliable, prompt, imaging-free temporary pacing with safe post-procedure ambulation.
San Clemente, CA
Joined May 2018
- Tweets18
- Following2
- Followers108
- Likes0
Wrap up #HRS24 on Sunday, May 19 with two additional AtaCor scientific sessions. Add these sessions to your HRS planner today and see you in Boston! #HRS2024 #epeeps eppro01.ativ.me/src/EventPil…
Another AtaCor Scientific Session at HRS on Saturday, May 18! Join us to learn more about our novel EV-ICD lead system. Stay outside of the vascular system! #HRS2024 #HRS24 #epeeps eppro01.ativ.me/src/EventPil…
Join us Wed May 15 in Boston at the Stanford Biodesign New Arrhythmia Technologies Retreat where over 60 international thought leaders and innovators will discuss emerging technologies, including AtaCor's solutions! Register today sto.stanfordtickets.org/2024… #epeeps #HRS2024
#HRS2024 is right around the corner. AtaCor’s EV-ICD and EV temporary pacing lead systems will be featured in several abstract presentations throughout the event! Mark your calendars to join us for these presentations! #epeeps eppro01.ativ.me/src/EventPil…
We are excited to announce that we have successfully closed $28M in our Series C financing round!! Congrats to the entire #AtaCor team on this important milestone! Read the full announcement here. prnewswire.com/news-releases…
#cardiology #CRM #EVICD
AtaCor Medical completes enrollment in its initial acute extravascular ICD study, designed to evaluate delivery of a novel EV-ICD lead and defibrillation success when connected to commercially available ICD systems.
businesswire.com/news/home/2…
AtaCor Medical took home the “Deal of the Year” award at the @OctaneOC #HighTechAwards ceremony on Thursday, September 23. The reception was held at the Balboa Bay Resort in Newport Beach, CA.
ALT Rick Sanghera, cofounder and CEO of AtaCor Medical, accepts the “Deal of the Year” award at OCTANe’s 2021 High Tech Awards ceremony.
Following a successful $25M round of financing, AtaCor Medical has been chosen as a finalist in the 27th annual @OctaneOC #HighTechAwards in the “Deal of the Year” category. Winners will be announced at the award ceremony Thursday, September 23 in Newport Beach.
Join us at Heart Rhythm Society 2021 July 28-31 in Boston as Dr. Martin Burke presents new data to support the use of an entirely extracardiac temporary pacing lead system.
#HeartRhythmSociety #ExtracardiacPacing #AtaCorMedical #TemporaryPacing
ALT Join us at Heart Rhythm Society 2021 July 28-31 in Boston as Dr. Martin Burke presents new data to support the use of an entirely extracardiac temporary pacing lead system.
Advancing the Standard of #CardiacPacing:
$25M Series B financing secured to support development of a novel #ExtracardiacPacing system designed to leave the heart completely untouched—for prompt pacing without the drawbacks of traditional methods:
businesswire.com/news/home/2…
Dr. Anne-Floor Quast presenting development data for AtaCor's extracardiac pacing system. Pacing without touching the heart is feasible and may offer an important new option for patients requiring temporary and/or permanent pacing therapy.
#HRS2019 #atacormedical
Cardiac pacing without touching the heart... AtaCor Medical announces completion of a $8.8M Series A financing to support development of its novel, extravascular substernal cardiac pacing system. businesswire.com/news/home/2…
